Biosimilars Primer

- Level: Intermediate
- CPE: 1.0 Credits
- Time: 65 Minutes
Biosimilars Primer examines the development of complex biologic medicines, illustrating how minor manufacturing adjustments can impact performance and how regulatory agencies, such as the FDA and EMA, evaluate safety and efficacy. Real-world case studies demonstrate the impact of biosimilars in clinical practice.
- Learn how companies gain regulatory approval for a biosimilar
- Discover sources of variation between two manufacturing campaigns using identical inputs
- Explore immunogenicity and its implications for adverse reactions in patients receiving biosimilar treatments
- Best Value: Unlimited Learning
- Purchase Single Course
Choose your subscription and start exploring a rich library of expert led, on-demand biotech training.
- Up to 12-month unlimited access
- Content designed for all skill levels: Beginner to Advanced
- CPE credits included with every course
- Learn at your own pace
- Choose the subscription plan that fits your goals
Get full access to this course with a one time purchase.
- 1-month access to all course material
- CPE credits included
- No subscription required
- Self-paced and on-demand
- Ideal for focused, one-off learning
- Overview
- Agenda
- Features
- Justify This Training
- FAQ
Watch Trailer
Agenda
- Proteins
Details the way protein structure influences the function of biosimilars.
- Biologics
Lists the characteristics of biologics/biosimilars.
- Biosimilars
Explains the design principles behind biosimilars and the concept that “the product is the process,” referring to the critical role of manufacturing in determining a biosimilar’s safety, purity, and efficacy.
- Manufacturing
Explore the differences between biosimilars and their reference products, including variations in manufacturing and their potential safety implications.
- Safety and Regulation
States the FDA and EMA requirements for biosimilar approval and the underlying regulatory principles involved.
- Biosimilars Case Studies
Explore four real-world case studies to gain insight into the challenges and benefits of biosimilar production.
Features
- Closed Captioning in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
- Transcripts in English, Spanish, French, French Canadian, Hindi, Japanese, Korean, Mandarin, Russian, Standard Arabic
- Course materials
- Real-time tracking
- Progress reporting
- Accessibility features
- Corporate account upgrades
- LinkedIn certificate attachment
- Verified certificates
Justify This Training
View our “Justify This Training” checklist and letter to craft a persuasive request that clearly shows the value of Biotech Primer training to your role and your company. This step-by-step guide helps you highlight ROI, align with business goals, and increase your chances of getting this course approved.
FAQ
Our Executive
Certifications
Cannot make our live class? Consider one of our Executive Certifications.

Drug Development Executive Certification
- Level:Beginner
- CPE:13.50 Credits
- Time:10.5 Hours
- Total:12 Courses

Biotechnology Executive Certification
- Level:Beginner
- CPE:14.50 Credits
- Time:12 Hours
- Total:12 Courses

Drug Manufacturing Executive Certification
- Level:Beginner
- CPE:14.50 Credits
- Time:10 Hours
- Total:11 Courses

Medical Device Executive Certification
- Level:Beginner
- CPE:12.00 Credits
- Time:8 Hours
- Total:9 Courses